Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 33 results
Filters: First Letter Of Title is M  [Clear All Filters]
Found 33 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

M

Stone ND, Dunaway SB, Flexner C, et al. "Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects." Antimicrob. Agents Chemother.. 2007;51(7):2351-8.
Robertson K, Kumwenda J, Supparatpinyo K, et al. "A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings." J. Neurovirol.. 2011;17(5):438-47.
Motsinger AA, Ritchie MD, Shafer RW, et al. "Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study." Pharmacogenet. Genomics. 2006;16(11):837-45.
J Critchfield W, Lemongello D, Walker DH, et al. "Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection." J. Virol.. 2007;81(11):5460-71.
Schifitto G, Zhang J, Evans SR, et al. "A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment." Neurology. 2007;69(13):1314-21.
Shulman NS, Kassaye SG, Winters MA, Johnston E, Katzenstein DA. "More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175." J. Infect. Dis.. 2007;196(2):328-9; author reply 329-30.
Lederman MM, Penn-Nicholson A, Stone SF, Sieg SF, Rodriguez B. "Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption." Curr Opin HIV AIDS. 2007;2(1):56-61.
Gross R, Tierney C, Andrade A, et al. "Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial." Arch. Intern. Med.. 2009;169(13):1224-32.
Johnson BA, Ribaudo H, Gulick RM, Eron JJ. "Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times." Biometrics. 2013;69(3):732-40.
Svensson EM, Aweeka F, Park J-G, Marzan F, Dooley KE, Karlsson MO. "Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis." Antimicrob. Agents Chemother.. 2013;57(6):2780-7.
Mulligan K, Parker RA, Komarow L, et al. "Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial." J. Acquir. Immune Defic. Syndr.. 2006;41(5):590-7.
Canter JA, Haas DW, Kallianpur AR, et al. "The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy." Pharmacogenomics J.. 2008;8(1):71-7.
Grady BJ, Samuels DC, Robbins GK, et al. "Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384." J. Acquir. Immune Defic. Syndr.. 2011;58(4):363-70.
Hulgan T, Stein JH, Cotter BR, et al. "Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation." AIDS Res. Hum. Retroviruses. 2013;29(10):1293-9.
Abraham AG, Lau B, Deeks S, et al. "Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america." Am. J. Epidemiol.. 2011;174(6):727-35.
Pence BWells, Reif S, Whetten K, et al. "Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South." South. Med. J.. 2007;100(11):1114-22.
Castillo-Mancilla JR, Cohn SE, Krishnan S, et al. "Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials." HIV Clin Trials. 2014;15(1):14-26.
Sacktor N, Miyahara S, Deng L, et al. "Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial." Neurology. 2011;77(12):1135-42.
Brenchley JM, Price DA, Schacker TW, et al. "Microbial translocation is a cause of systemic immune activation in chronic HIV infection." Nat. Med.. 2006;12(12):1365-71.
Krishnan S, Schouten JT, Atkinson B, et al. "Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals." J. Acquir. Immune Defic. Syndr.. 2012;61(3):381-9.
Shikuma CM, Yang Y, Glesby MJ, et al. "Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)." J. Acquir. Immune Defic. Syndr.. 2007;44(5):540-50.
Tebas P, Henry WKeith, Matining R, et al. "Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk." PLoS ONE. 2008;3(4):e2021.
Hermes A, Squires K, Fredrick L, et al. "Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected women." HIV Clin Trials. 2012;13(6):308-23.
Raboud JM, Diong C, Carr A, et al. "A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy." HIV Clin Trials. 2010;11(1):39-50.
Zhao Y, Navia BA, Marra CM, et al. "Memantine for AIDS dementia complex: open-label report of ACTG 301." HIV Clin Trials. 2010;11(1):59-67.
Schifitto G, Navia BA, Yiannoutsos CT, et al. "Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study." AIDS. 2007;21(14):1877-86.
Schacker TW, Bosch RJ, Bennett K, et al. "Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV." J. Acquir. Immune Defic. Syndr.. 2010;54(1):59-62.
Twigg HL, Schnizlein-Bick CT, Weiden M, et al. "Measurement of antiretroviral drugs in the lungs of HIV-infected patients." HIV Ther. 2010;4(2):247-251.
Huang X-L, Fan Z, Borowski L, Rinaldo CR. "Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity." J. Leukoc. Biol.. 2008;83(6):1530-40.
Gupta SK, Kitch D, Tierney C, Melbourne K, Ha B, McComsey GA. "Markers of renal disease and function are associated with systemic inflammation in HIV infection." HIV Med.. 2015;16(10):591-8.

Pages